JP2024534901A5 - - Google Patents

Info

Publication number
JP2024534901A5
JP2024534901A5 JP2024514038A JP2024514038A JP2024534901A5 JP 2024534901 A5 JP2024534901 A5 JP 2024534901A5 JP 2024514038 A JP2024514038 A JP 2024514038A JP 2024514038 A JP2024514038 A JP 2024514038A JP 2024534901 A5 JP2024534901 A5 JP 2024534901A5
Authority
JP
Japan
Prior art keywords
composition according
subject
composition
synucleinopathy
lys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024514038A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024534901A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/075836 external-priority patent/WO2023034914A2/en
Publication of JP2024534901A publication Critical patent/JP2024534901A/ja
Publication of JP2024534901A5 publication Critical patent/JP2024534901A5/ja
Pending legal-status Critical Current

Links

JP2024514038A 2021-09-01 2022-09-01 シヌクレイノパチーの予防及び治療のための方法 Pending JP2024534901A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163239505P 2021-09-01 2021-09-01
US63/239,505 2021-09-01
PCT/US2022/075836 WO2023034914A2 (en) 2021-09-01 2022-09-01 Methods for the prevention and treatment of synucleinopathies

Publications (2)

Publication Number Publication Date
JP2024534901A JP2024534901A (ja) 2024-09-26
JP2024534901A5 true JP2024534901A5 (cg-RX-API-DMAC7.html) 2025-09-29

Family

ID=85413127

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024514038A Pending JP2024534901A (ja) 2021-09-01 2022-09-01 シヌクレイノパチーの予防及び治療のための方法

Country Status (10)

Country Link
US (1) US20240358806A1 (cg-RX-API-DMAC7.html)
EP (1) EP4395894A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024534901A (cg-RX-API-DMAC7.html)
KR (1) KR20240055785A (cg-RX-API-DMAC7.html)
CN (1) CN118119403A (cg-RX-API-DMAC7.html)
AU (1) AU2022337284A1 (cg-RX-API-DMAC7.html)
CA (1) CA3230300A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024002684A (cg-RX-API-DMAC7.html)
TW (1) TW202323275A (cg-RX-API-DMAC7.html)
WO (1) WO2023034914A2 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025137102A1 (en) * 2023-12-18 2025-06-26 Vaxxinity, Inc. Peptide immunogen compositions and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6906169B2 (en) * 2001-05-25 2005-06-14 United Biomedical, Inc. Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide
EP1572894B1 (en) * 2001-11-21 2016-04-13 New York University Synthetic immunogenic but non-deposit-forming polypeptides and peptides homologous to amyloid beta, prion protein, amylin, alpha synuclein, or polyglutamine repeats for induction of an immune response thereto
US8697082B2 (en) * 2002-11-01 2014-04-15 Neotope Biosciences Limited Prevention and treatment of synucleinopathic and amyloidogenic disease
GB201512203D0 (en) * 2015-07-13 2015-08-19 Lundbeck & Co As H Agents,uses and methods
JP2021508672A (ja) * 2017-06-16 2021-03-11 ユナイテッド ニューロサイエンスUnited Neuroscience シヌクレイノパチーの治療のためのアルファ−シヌクレインタンパク質のc末端からのペプチド免疫原及びその製剤

Similar Documents

Publication Publication Date Title
EP2583978B1 (en) Prevention and treatment of synucleinopathic and amyloidogenic disease
US20190300598A1 (en) Prevention and treatment of synucleinopathic and amyloidogenic disease
JP6041917B2 (ja) 疾患を治療するための化合物
EP1793855B1 (en) Prevention and treatment of synucleinopathic and amyloidogenic disease
US20080175838A1 (en) Prevention And Treatment of Synucleinopathic And Amyloidogenic Disease
US20110135660A1 (en) Prevention and treatment of synucleinopathic disease
US8697082B2 (en) Prevention and treatment of synucleinopathic and amyloidogenic disease
EP2450056A1 (en) Prevention and treatment of synucleinopathic and amyloidogenic disease
DK2118300T3 (en) PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC AND AMYLOIDOGENIC DISEASE
CA2730686A1 (en) Anti-amyloid immunogenic compositions, methods and uses
WO2010044464A1 (ja) 改変アミロイドβペプチド
US20160184416A1 (en) Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease
US20040146521A1 (en) Prevention and treatment of synucleinopathic disease
CA3230300A1 (en) Methods for the prevention and treatment of synucleinopathies
RU2024108344A (ru) Способы предотвращения и лечения синуклеинопатий
US20240254211A1 (en) Prevention and treatment of synucleinopathic and amyloidogenic disease
DK2583978T3 (en) PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC AND AMYLOIDOGENIC DISEASES
HK1260628A1 (en) Prevention and treatment of synucleinopathic and amyloidogenic disease
HK1228767A1 (en) Prevention and treatment of synucleinopathic and amyloidogenic disease
HK1184169B (en) Prevention and treatment of synucleinopathic and amyloidogenic disease
HK1138622B (en) Prevention and treatment of synucleinopathic and amyloidogenic disease
HK1161102A (en) Prevention and treatment of synucleinopathic disease